Liquidia, a Morrisville biopharmaceutical company founded on technology from chemist Joseph DeSimone, has raised $50 million through an initial offering of public stock. It begins trading on the Nasdaq on Thursday, July 26. DeSimone is a professor at UNC Chapel Hill and N.C. State University.
Liquidia, a Morrisville biopharmaceutical company founded on technology from chemist Joseph DeSimone, has raised $50 million through an initial offering of public stock. It begins trading on the Nasdaq on Thursday, July 26. DeSimone is a professor at UNC Chapel Hill and N.C. State University. News & Observer file photo
Liquidia, a Morrisville biopharmaceutical company founded on technology from chemist Joseph DeSimone, has raised $50 million through an initial offering of public stock. It begins trading on the Nasdaq on Thursday, July 26. DeSimone is a professor at UNC Chapel Hill and N.C. State University. News & Observer file photo